Human homocysteine catabolism: Three major pathways and their relevance to development of arterial occlusive disease

Journal of Nutrition

Volumn 126, Issue 4 SUPPL., 1996, Pages

  Dudman, Nicholas P B ^a,c   Guo, Xue Wei ^a   Gordon, Ross B ^b   Dawson, Paul A ^b   Wilcken, David E L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PRINCE HENRY HOSPITAL   (Australia)

Author keywords

betaine; folate; homocysteine; human; occlusive vascular disease

Indexed keywords

BETAINE; FOLIC ACID; HOMOCYSTEINE;

AMINO ACID METABOLISM; BLOOD VESSEL FUNCTION; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SULFATION; ENZYME ACTIVITY; FOLIC ACID DEFICIENCY; HOMOCYSTINURIA; HUMAN; METHYLATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE;

EID: 0029979229     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/126.suppl_4.1295s     Document Type: Conference Paper

References (20)

1. Boers, G H. J., Smals, A. H. G., Trijbels, F. J. M., Fowler, B., Bakkeren, J A. J. M., Schoonderwaldt, H. C., Kleijer, W. J. &. Kloppenborg, P. W. C. (1985) Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med. 313: 709-715.
2. Brown, J. C. C., Mills, G. A., Sadler, P. J. & Walker, V. (1989) 1H NMR studies of urine from premature and sick babies. Magn. Reson. Med. 11: 193-201.
3. Cools, M., Balzarini, J. & De Clercq, E. (1991) Mechanism of antiviral and cytotoxic action of (+/-)-6′beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase. Mol. Pharmacol. 39: 718-724.
4. Dudman, N. P. B., Kim, M. H., Wang, J., Wong, P. W. K., Wilcken, D. E. L., Marshall, M. D. & Kang, S-S. (1993a) Thermolabile methylenetetrahydrofolate reductase causes mild hyperhomocyst(e)inemia in patients with vascular disease. Am. J. Hum. Genet. 53 (suppl.): 899 (abs.).
5. Dudman, N. P. B., Tyrrell, P. A. & Wilcken, D. E. L. (1987) Homocystinuria: depressed plasma serine levels. Metabolism 36: 198-202.
6. Dudman, N. P. B., Wilcken, D. E. L., Wang, J., Lynch, J. F., Macey, D. & Lundberg, P. (1993b) Disordered methionine/homocysteine metabolism in premature vascular disease - its occurrence, cofactor therapy and enzymology. Arterioscler. Thromb. 13: 1253-1260.
7. Finkelstein, J. D. & Martin, J. J. (1984) Methionine metabolism in mammals - distribution of homocysteine between competing pathways. J. Biol. Chem. 259: 9508-9513.
8. Kang, S-S., Wong, P. W. K. & Becker, N. (1979) Protein-bound homocyst(e)ine in normal subjects and in patients with homocystinuria. Pediatr. Res. 13: 1141-1143.
9. Miller, M. W., Duhl, D. M., Winkes, B. M., Arredondo-Vega, F., Saxon, P. J., Wolff, G. L., Epstein, C. J., Hershfield, M. S. & Barsh, G. S. (1994) The mouse lethal nonagouti (a(x)) mutation deletes the S-adenosylhomocysteine hydrolase (Ahcy) gene. EMBO J. 13: 1806-1816.
10. Mudd, S. H., Havlik, R., Levy, H. L., McKusick, V. A. & Feinleib, M. (1981) A study of cardiovascular risk in heterozygotes for homocystinuria. Am. J. Hum. Genet. 33: 883-893.
11. Mudd, S. H. & Poole, J. R. (1975) Labile methyl balances for normal humans on various dietary regimens. Metabolism 24: 721-735.
12. Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B., Pyeritz, R. E., Andria, G., Boers, G. H. J., Bromberg, I. L., Cerone, R., Fowler, B., Grobe, H., Schmidt, H. & Schweitzer, L. (1985) The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am. J. Hum. Genet. 37: 1-31.
13. Perry, T. L. (1974) Homocystinuria. In: Heritable Disorders of Amino Acid Metabolism 2nd ed. (Nyhan, W. L., ed.), pp. 395-428. Wiley, New York, NY.
14. Selhub, J. & Miller, J. W. (1992) The pathogenesis of hyperhomocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr. 55: 131-138.
15. Smolin, L. A., Benevenga, N. J. & Berlow, S. (1981) The use of betaine for the treatment of homocystinuria. J. Pediatr. 99: 467-472.
16. Ueland, P. M., Refsum, H. & Brattstrom, L. (1992) Plasma homocysteine and cardiovascular disease. In: Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function (Francis, R. B., ed.), pp. 183-236. Marcel Dekker, New York, NY.
17. Wang, J., Dudman, N. P. B., Wilcken, D. E. L. & Lynch, J. F. (1992) Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease. Atherosclerosis 97: 97-106.
18. Wilcken, D. E. L., Dudman, N. P. B. & Tyrrell, P. A. (1985) Homocystinuria due to cystathionine β-synthase deficiency - the effects of betaine in pyridoxine responsive patients. Metabolism 34: 1115-1121.
19. Wilcken, D. E. L., Gupta, V. J. & Betts, A. K. (1981) Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clin. Sci. 61: 743-749.
20. Wilcken, D. E. L., Wilcken, B., Dudman, N. P. B. & Tyrrell, P. A. (1983) Homocystinuria - the effects of betaine in the treatment of patients not responsive to pyridoxine. N. Engl. J. Med. 309. 448-453.